ABBOTT LABORATORIES
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
ABT$110.51+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Comprehensive Income
| Year Ended December 31 | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net Earnings | $13,402 | $5,723 | $6,933 |
| Foreign currency translation gain (loss) adjustments | (1,001) | 229 | (894) |
| Net actuarial gains (losses) and prior service cost and credits and amortization of net actuarial losses and prior service cost and credits, net of taxes of $228 in 2024, $31 in 2023 and $330 in 2022 | 765 | 117 | 1,177 |
| Net gains (losses) on derivative instruments designated as cash flow hedges, net of taxes of $48 in 2024, $(66) in 2023 and $11 in 2022 | 169 | (134) | 40 |
| Other Comprehensive Income (Loss) | (67) | 212 | 323 |
| Comprehensive Income | $13,335 | $5,935 | $7,256 |
| Supplemental Accumulated Other Comprehensive Income (Loss) Information, net of tax as of December 31: | |||
| Cumulative foreign currency translation (loss) adjustments | $(7,505) | $(6,504) | $(6,733) |
| Net actuarial (losses) and prior service (cost) and credits | (611) | (1,376) | (1,493) |
| Cumulative gains (losses) on derivative instruments designated as cash flow hedges | 210 | 41 | 175 |
| Accumulated other comprehensive income (loss) | $(7,906) | $(7,839) | $(8,051) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.